Table 3.

Susceptibility of E. coli carrying cloned β-lactamase enzymes

EnzymeMIC (mg/L)
Amoxicillina
Ceftazidimea
CFXCPTATMMEM
aloneAVI (0.5)AVI (1)AVI (2)AVI (4)CLA (1)CLA (2)CLA (4)CLA (8)aloneAVI (0.5)AVI (1)AVI (2)AVI (4)
Noneb8222188840.250.250.250.250.2580.1250.1250.03
PDC-1c6484216464643210.250.250.250.25160.250.250.015
CTX-M-15>1024844216168840.250.250.250.25>512>512320.03
GES-112816842321616440.50.50.250.251610.250.015
GES-712816842643216432210.50.532220.03
GES-52561684212864321610.50.50.250.2580.50.250.06
GES-12102484421684264640.1250.060.0616240.03
GES-2025684421286432160.50.250.250.250.2540.50.1250.06
PER-2>102425612812832161688512321642512165120.03
PER-351264168444421284210.52564640.015
PER-4512512512256256884425625625625625651232640.03
EnzymeMIC (mg/L)
Amoxicillina
Ceftazidimea
CFXCPTATMMEM
aloneAVI (0.5)AVI (1)AVI (2)AVI (4)CLA (1)CLA (2)CLA (4)CLA (8)aloneAVI (0.5)AVI (1)AVI (2)AVI (4)
Noneb8222188840.250.250.250.250.2580.1250.1250.03
PDC-1c6484216464643210.250.250.250.25160.250.250.015
CTX-M-15>1024844216168840.250.250.250.25>512>512320.03
GES-112816842321616440.50.50.250.251610.250.015
GES-712816842643216432210.50.532220.03
GES-52561684212864321610.50.50.250.2580.50.250.06
GES-12102484421684264640.1250.060.0616240.03
GES-2025684421286432160.50.250.250.250.2540.50.1250.06
PER-2>102425612812832161688512321642512165120.03
PER-351264168444421284210.52564640.015
PER-4512512512256256884425625625625625651232640.03

AVI, avibactam; CLA, clavulanic acid; CFX, cefuroxime; CPT, ceftaroline; ATM, aztreonam; MEM, meropenem.

aThese drugs were tested alone or in combination with various concentrations, indicated in parentheses in mg/L, of avibactam or clavulanic acid.

bThe pSU19 vector alone was present in this strain.

cThe chromosomal class C β-lactamase was cloned from P. aeruginosa as a control enzyme.

Table 3.

Susceptibility of E. coli carrying cloned β-lactamase enzymes

EnzymeMIC (mg/L)
Amoxicillina
Ceftazidimea
CFXCPTATMMEM
aloneAVI (0.5)AVI (1)AVI (2)AVI (4)CLA (1)CLA (2)CLA (4)CLA (8)aloneAVI (0.5)AVI (1)AVI (2)AVI (4)
Noneb8222188840.250.250.250.250.2580.1250.1250.03
PDC-1c6484216464643210.250.250.250.25160.250.250.015
CTX-M-15>1024844216168840.250.250.250.25>512>512320.03
GES-112816842321616440.50.50.250.251610.250.015
GES-712816842643216432210.50.532220.03
GES-52561684212864321610.50.50.250.2580.50.250.06
GES-12102484421684264640.1250.060.0616240.03
GES-2025684421286432160.50.250.250.250.2540.50.1250.06
PER-2>102425612812832161688512321642512165120.03
PER-351264168444421284210.52564640.015
PER-4512512512256256884425625625625625651232640.03
EnzymeMIC (mg/L)
Amoxicillina
Ceftazidimea
CFXCPTATMMEM
aloneAVI (0.5)AVI (1)AVI (2)AVI (4)CLA (1)CLA (2)CLA (4)CLA (8)aloneAVI (0.5)AVI (1)AVI (2)AVI (4)
Noneb8222188840.250.250.250.250.2580.1250.1250.03
PDC-1c6484216464643210.250.250.250.25160.250.250.015
CTX-M-15>1024844216168840.250.250.250.25>512>512320.03
GES-112816842321616440.50.50.250.251610.250.015
GES-712816842643216432210.50.532220.03
GES-52561684212864321610.50.50.250.2580.50.250.06
GES-12102484421684264640.1250.060.0616240.03
GES-2025684421286432160.50.250.250.250.2540.50.1250.06
PER-2>102425612812832161688512321642512165120.03
PER-351264168444421284210.52564640.015
PER-4512512512256256884425625625625625651232640.03

AVI, avibactam; CLA, clavulanic acid; CFX, cefuroxime; CPT, ceftaroline; ATM, aztreonam; MEM, meropenem.

aThese drugs were tested alone or in combination with various concentrations, indicated in parentheses in mg/L, of avibactam or clavulanic acid.

bThe pSU19 vector alone was present in this strain.

cThe chromosomal class C β-lactamase was cloned from P. aeruginosa as a control enzyme.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close